Cell Design Labs
AcquiredSouth San Francisco, United States · $34.4M raised
- Headquarters
- South San Francisco, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- celldesignlabs.com
- Total Funding
- $34.4M
- Last Round
- $34.4M Series AJun 2016
- Rounds
- 1
- Acquisition Date
- Dec 2017
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Cell Design Labs was a San Francisco-based biotechnology company that developed novel synthetic biology platforms for engineering next-generation cell-based therapies, including its proprietary synNotch and Throttle technologies. The company focused on cellular immunotherapy for blood cancers and solid tumors, leveraging programmable cell design to improve the precision and safety of CAR-T therapies. Cell Design Labs was acquired by Gilead Sciences and its Kite Pharma subsidiary in December 2017 for up to $567 million.
Summary
Cell Design Labs is a Biotech company based in South San Francisco, United States. It has raised $34.4M in total across 1 round, most recently a $34.4M Series A round in Jun 2016. Investors include Kleiner Perkins, Kite Pharma and Mission Bay Capital.
Funding & Exit History
Dec 2017
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cell-design-labs"><img src="https://indexed.vc/api/badge/company/cell-design-labs" alt="Cell Design Labs on Indexed.vc" width="260" height="76" /></a>